share_log

Brookline Capital Initiates Coverage On Forte Biosciences With Buy Rating, Announces Price Target of $4

Brookline Capital Initiates Coverage On Forte Biosciences With Buy Rating, Announces Price Target of $4

布魯克林資本以買入評級啓動對Forte Biosciences的報道,宣佈目標股價爲4美元
Benzinga ·  05/30 17:56

Brookline Capital analyst Kumaraguru Raja initiates coverage on Forte Biosciences (NASDAQ:FBRX) with a Buy rating and announces Price Target of $4.

布魯克林資本分析師庫馬拉古魯·拉賈以買入評級啓動了對Forte Biosciences(納斯達克股票代碼:FBRX)的報道,並宣佈目標股價爲4美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論